Connect with us

Technology

Generative AI Market worth $1,658.97 billion by 2033 – Report by MarketsandMarkets™

Published

on

DELRAY BEACH, Fla., July 31, 2026 /PRNewswire/ — According to MarketsandMarkets™, the global Generative AI Market is projected to grow from USD 185.45 billion in 2026 and to reach USD 1,658.97 billion by 2033, at a Compound Annual Growth Rate (CAGR) of 36.8% during the forecast period.

Browse 900 market data Tables and 70 Figures spread through 700 Pages and in-depth TOC on “Generative AI Market – Global Forecast to 2033”

Generative AI Market Size & Forecast:

Market Size Available for Years: 2021–20332025 Market Size: USD 119.51 billion2026 Market Size: USD 185.45 billion2033 Projected Market Size: USD 1,658.97 billionCAGR (2026–2033): 36.8%

Generative AI Market Trends & Insights:

Growth is being driven by the rapid integration of foundation models, multimodal AI, copilots, and autonomous agents into enterprise applications and workflows.By offering, the infrastructure segment is estimated to account for the largest share of 46.1% in 2026.By data modality, the text data modality segment is estimated to account for the largest share of 39.1% in 2026.By application, the content generation & management segment is poised to dominate the market in 2026.By vertical, the enterprise gen AI end users segment is slated for the fastest growth during the forecast period.Asia Pacific is poised to register the highest growth rate of 40.3% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142870584

Growth is being driven by the rapid commercialization of foundation models, enterprise copilots, multimodal systems, and agentic AI across software development, customer operations, research, analytics, content creation, and business-process automation. Organizations are moving beyond small-scale pilots and embedding generative AI into core workflows, creating demand for computing infrastructure, model-development platforms, customization, enterprise data integration, governance, cybersecurity, and managed services. Improvements in model reasoning, context handling, tool use, and inference efficiency are further expanding commercially viable use cases. However, high infrastructure costs, model reliability concerns, data-security risks, intellectual-property issues, regulatory uncertainty, and difficulty demonstrating returns on investment may slow adoption, particularly among smaller organizations and highly regulated industries.

Large-scale investment in accelerators and AI-optimized data centers will keep Gen AI infrastructure at the forefront of spending in 2026

By offering, the infrastructure segment is expected to account for the largest share of the Generative AI Market in 2026, supported by sustained spending on accelerator chips, high-bandwidth memory, storage systems, and high-speed networking required for model training and inference. The growing size and complexity of foundation models, multimodal workloads, and long-running AI agents are increasing demand for dense computing clusters, optimized server architectures, and low-latency interconnects. Hyperscale cloud providers, model developers, sovereign AI programs, and large enterprises are investing heavily in infrastructure to expand training capacity and support production-scale inference. Demand is also moving beyond GPUs toward integrated AI systems that combine accelerators, memory, networking, storage, and software optimization. As generative AI adoption expands across cloud, on-premises, and edge environments, hardware vendors are positioned to benefit from both new infrastructure deployments and the continuing replacement of general-purpose systems with AI-optimized architectures.

Request for Proposal: https://www.marketsandmarkets.com/requestsampleNew.asp?id=142870584

Healthcare, pharmaceuticals & life sciences segment to grow fastest during the forecast period as generative AI moves deeper into research and clinical workflows

The healthcare, pharmaceuticals & life sciences segment is projected to record the highest CAGR among end-user segments during the forecast period. Generative AI is increasingly being applied to drug discovery, clinical-document summarization, medical knowledge retrieval, patient communication, regulatory documentation, trial design, scientific research, and administrative automation. Multimodal gen AI models are also creating opportunities to combine clinical text, medical images, laboratory information, genomic data, and research literature within integrated decision-support environments. Pharmaceutical companies are adopting generative AI to accelerate target identification, molecule design, evidence synthesis, and submission preparation, while healthcare providers are exploring its use in documentation, coding, care coordination, and patient engagement. Growth will be supported by demand for domain-specific models, secure deployment environments, explainability, data privacy, and human oversight. Although regulatory requirements and concerns regarding accuracy may moderate deployment, the high value of improved research productivity and reduced administrative burden is expected to sustain strong investment.

A dense concentration of hyperscalers, frontier-model developers, and enterprise technology buyers secures North America’s position as the largest regional market in 2026

North America is expected to account for the largest share of the Generative AI Market in 2026 because of its concentration of semiconductor companies, hyperscale cloud providers, foundation-model developers, enterprise software vendors, research institutions, startups, and large technology buyers. The region benefits from substantial data-center investment, mature cloud infrastructure, strong venture funding, and early enterprise adoption across BFSI, healthcare, defense, professional services, media and entertainment, and IT. US-based companies occupy leading positions across the generative AI value chain, including accelerators, cloud compute, models, development platforms, governance systems, applications, and consulting services. Enterprises in the region are also progressing from isolated tools toward integrated deployments connected with organizational data, business applications, and automated workflows. Continued investment in AI infrastructure, energy capacity, cybersecurity, and workforce development is expected to reinforce North America’s leadership as generative AI adoption scales.

Request Pricing: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=142870584

Top Companies in Generative AI Market:

The Top Companies in Generative AI Market are NVIDIA (US), Microsoft (US), Google (US), Amazon Web Services (US), IBM (US), OpenAI (US), Anthropic (US), Meta (US), Mistral AI (France), and Cohere (Canada), among others. These companies compete across hardware, foundation models, development platforms, governance and security systems, agentic AI platforms, applications, and services. The report also examines specialist and emerging vendors that are expanding innovation in model development, inference optimization, multimodal generation, enterprise agents, AI governance, and industry-specific applications.

Browse Adjacent Markets: Artificial Intelligence (AI) Market Research Reports & Consulting

Related Market Reports:

Artificial Intelligence (AI) Market by Offering [Hardware (AI Chips, Memory, Storage), Software, Services], Technology (ML, NLP, Generative AI, Neurosymbolic AI), Business Function (Operations & Supply Chain, Sales & Marketing) – Global Forecast to 2033

AI Agents Market by Agent Role (Productivity & Personal Assistant, Sales, Marketing, Code Generation, Operations & Supply Chain), Offering (Vertical AI Agents, Horizontal AI Agents), Agent System (Single Agent, Multi Agent) – Global Forecast to 2030

About MarketsandMarkets™  

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on TwitterLinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/generative-ai.asp

View original content to download multimedia:https://www.prnewswire.com/news-releases/generative-ai-market-worth-1-658-97-billion-by-2033—report-by-marketsandmarkets-302839836.html

SOURCE MarketsandMarkets

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Clarkson University Partners with Industry Executives to Launch Introduction to Manufacturing Seminar Course

Published

on

By

POTSDAM, N.Y., July 31, 2026 /PRNewswire/ — As manufacturers race to adopt artificial intelligence, strengthen supply chains and expand production, Clarkson University is giving students a front-row seat to the industry’s transformation through a new seminar course led by executives from some of the world’s leading manufacturing companies.

The new one-credit seminar, Introduction to Manufacturing, will launch during the fall 2026 semester through Clarkson University’s Center for Advanced Materials Processing (CAMP). The course will introduce students to the technical, business and strategic dimensions of modern manufacturing.

The weekly seminar is open to graduate students and upper-class undergraduates from all majors, including non-engineering disciplines. Members of the public are also invited to attend the lectures free of charge. Registration information is available on Clarkson’s Introduction to Manufacturing webpage.

The seminar will feature senior executives, CEOs, entrepreneurs, policymakers, and technology leaders who have helped shape industries ranging from semiconductors and aerospace to medical devices, consumer products, robotics, advanced sensors, and modular construction. Speakers will share insights into how products move from concept to commercialization, the challenges of leading complex manufacturing organizations, and the technologies transforming factories around the world.

“Manufacturing is evolving rapidly, and students entering the workforce and professionals need an understanding of both the technology and the business decisions that drive our industry,” said John Whitman, corporate vice president at Micron Technology Inc. “Clarkson’s Introduction to Manufacturing course creates an opportunity for students and professionals to hear directly from industry leaders about the challenges, opportunities and innovations shaping manufacturing today.”

Students and professionals will also explore manufacturing strategy, product development, operations, automation, artificial intelligence, smart manufacturing, supply chain resilience, digital transformation, quality systems, sustainability, workforce development, and the growing role of manufacturing in economic competitiveness and national security.

“Advanced manufacturing continues to be a major driver of New York’s economy, making workforce development more important than ever,” said Hope Knight, president, CEO and commissioner of Empire State Development. “Clarkson’s Introduction to Manufacturing course gives students and professionals valuable exposure to industry perspectives while helping prepare the next generation of talent that will support continued growth across the state’s manufacturing sector.”

The course will be taught and moderated by Fram Akiki ’86, president of Joun Technologies and a member of Clarkson University’s Board of Trustees. Akiki has more than 40 years of experience in the semiconductor industry, including executive leadership positions with IBM, Qualcomm and Siemens.

Featured speakers for the Fall 2026 seminar include:

Priya Abani ’97, CEO and president, AliveCor Inc.Greg Akiki ’82, senior director, GlobalFoundriesTom Capek P’15, senior vice president and chief engineer, Corning Inc.Hannah Henley ’10, president, INFICON Intelligent Sensor SolutionsBill Kleftis, CEO, Spartan Consulting ServicesSteve Landry, retired executive, TreeHouse Foods, The J.M. Smucker Co. and Procter & GambleHope Knight, president, CEO and commissioner, Empire State DevelopmentKen McAvey ’97, senior vice president and general manager, GlobalFoundriesRoland Menassa ’85, vice president of Manufacturing Technology, Skyline Champion Corp.Chris Monoski, executive vice president of Manufacturing, CACI International Inc.Elisabeth Reynolds, professor, Massachusetts Institute of Technology, and former White House National Economic Council officialAmy Villeneuve ’86, board director, advisor and former COO and president, Amazon RoboticsJohn Whitman, corporate vice president, Micron Technology Inc.

Introduction to Manufacturing is the third executive seminar series launched at Clarkson, following the success of Introduction to Semiconductors and Introduction to Energy and Utilities. Together, the courses connect students and professionals with industry experts while providing insight into emerging technologies, workforce trends and the challenges shaping critical sectors of the global economy.

For more information about Introduction to Manufacturing, visit the Clarkson Introduction to Manufacturing webpage

View original content to download multimedia:https://www.prnewswire.com/news-releases/clarkson-university-partners-with-industry-executives-to-launch-introduction-to-manufacturing-seminar-course-302840142.html

SOURCE Clarkson University

Continue Reading

Technology

Government of Canada renames Canada Impact+ Research Chairs program in honour of Eddie Goldenberg

Published

on

By

New name recognizes Mr. Goldenberg’s decades of leadership in advancing Canadian research and innovation

OTTAWA, ON, July 31, 2026 /CNW/ — Today, the Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, and the Honourable Marjorie Michel, Minister of Health, announced that the Canada Impact+ Research Chairs program has been renamed the Eddie Goldenberg Research Chairs of Canada.

The name change honours the late Eddie Goldenberg, a distinguished public servant and former chief of staff to Prime Minister Jean Chrétien, whose decades of leadership helped shape Canada’s modern research and innovation landscape. A passionate advocate of excellence and opportunity, Mr. Goldenberg recognized that attracting the world’s brightest minds was essential to Canada’s prosperity and global competitiveness. His commitment to strengthening Canada’s research ecosystem helped inspire the ideas and collaborations that continue to attract exceptional talent to Canada today.

Working alongside the Right Honourable David Johnston, former Governor General of Canada, and Dr. Alan Bernstein, Mr. Goldenberg helped play a pivotal role in advancing the Canada Global Impact+ Research Talent Initiative, launched in December 2025 as part of a $1.7 billion investment announced in Budget 2025. The initiative reflects a conviction that guided Mr. Goldenberg throughout his life and career: that Canada’s greatest strength lies in the talent, ideas and ambition of its people.

At the heart of this investment is the Eddie Goldenberg Research Chairs of Canada, which will provide up to $1 billion over 12 years to support Canadian post-secondary institutions in recruiting exceptional international researchers and expatriate Canadian researchers leading transformational research projects. These chairs will help ensure that the next generation of researchers, innovators and leaders have the opportunity to build their futures in Canada and contribute to discoveries that will benefit people across the country and around the world.

By honouring Eddie Goldenberg in this way, we recognize not only his extraordinary contributions to public service but also his lifelong commitment to building a stronger Canada–one that attracts the best and brightest, supports bold ideas and believes in the power of knowledge to shape a better future.

Quotes

“Eddie Goldenberg devoted his life to advancing Canada’s ambitions and strengthening our place in the world. His vision and unwavering belief in the power of research, innovation and talent helped shape the institutions and investments that continue to fuel our country’s success. Renaming our world-class international research chairs program in his honour is a fitting tribute to his extraordinary legacy and a commitment to carrying his vision forward by inspiring the next generation of global research leaders to choose Canada.”
– The Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions

“Research is one of Canada’s greatest strengths. Throughout his career, Eddie Goldenberg helped foster an environment where bold ideas could grow into lasting impact. The renaming of this program honours his contributions to strengthening Canada’s research ecosystem and advancing discovery.”
– The Honourable Marjorie Michel, Minister of Health

Quick facts

The Eddie Goldenberg Research Chairs of Canada remains the centrepiece of the Canada Global Impact+ Research Talent Initiative. The names of the initiative’s other three programs remain unchanged:Canada Impact+ Emerging Leaders programCanada Impact+ Research Infrastructure FundCanada Impact+ Research Training AwardsAll four programs under this initiative will continue to operate under the same objectives, eligibility criteria, and terms and conditions.After a career spanning more than three decades in public policy and public affairs, Eddie Goldenberg served as chief of staff to Prime Minister Jean Chrétien in 2003.In 2013, Mr. Goldenberg was appointed a Member of the Order of Canada in recognition of his contributions to public policy in Canada and his championing of innovation and research excellence.

Stay connected

Find more services and information on the Innovation, Science and Economic Development Canada website.

Follow Innovation, Science and Economic Development Canada on social media.
X (Twitter): @ISED_CA | Facebook: Canadian Innovation | Instagram: @cdninnovation | LinkedIn: Innovation, Science and Economic Development Canada

SOURCE Innovation, Science and Economic Development Canada

Continue Reading

Technology

In HelloNation, Prescription Savings Expert Carl Stecker Outlines How to Lower Prescription Costs Without Insurance

Published

on

By

Uninsured Patients Have More Tools to Reduce Prescription Drug Costs Than Many Realize, From Generics to Patient Assistance Programs.

GREENVILLE, S.C., July 31, 2026 /PRNewswire/ — How can people without health insurance lower what they pay for prescription medications? A HelloNation article details practical strategies for reducing prescription costs without insurance, walking through options from generic medications and pharmacy price comparison to community health resources and manufacturer assistance programs.

The article starts with generic medications as the first and most accessible option for uninsured patients. A generic drug contains the same active ingredient as its brand-name equivalent and must meet the same safety and effectiveness standards set by the Food and Drug Administration. Prices for generic medications are typically far lower than brand-name versions, sometimes by 80 percent or more, making this one of the most immediate ways to reduce what a patient pays at the pharmacy.

Pharmacy price comparison is described in the article as one of the most effective steps uninsured patients can take. Prescription drug prices are not fixed across all pharmacies, and the same medication can cost significantly different amounts depending on where it is purchased. Online price comparison tools allow patients to search for a specific drug and see what multiple pharmacies in their area charge, with some patients finding savings of 50 percent or more by filling a prescription at a different nearby location.

Discount prescription programs are also highlighted as a widely available resource that does not require insurance enrollment. Prescription Savings Expert Carl Stecker’s work aligns closely with this part of the article, which explains that patients can present a discount card or use a smartphone app at the pharmacy counter to receive a reduced price, sometimes lower than what insured patients pay through their own coverage. Many of these programs are free to join and accepted at thousands of pharmacies nationwide.

The article encourages patients to speak openly with their pharmacist about cost, noting that this step is often overlooked. Pharmacists are knowledgeable about pricing options and may be aware of discounts, alternative formulations, or therapeutic substitutes that a physician has not mentioned. In some cases, a pharmacist can contact a prescribing doctor to discuss whether a lower-cost alternative would work just as well for the patient.

Pharmaceutical manufacturers offer patient assistance programs for many brand-name drugs, the article notes. These programs are designed to help people who cannot afford their medication, particularly those who are uninsured or who have exhausted other options. Many programs provide medications at no cost or at a significantly reduced price to qualifying patients, with information typically available through the drug manufacturer’s website or through a pharmacist.

Federally qualified health centers and community health clinics are identified as another resource for patients without insurance. These facilities serve patients on a sliding fee scale based on income and many have arrangements with local pharmacies to provide medications at discounted prices. Some states also operate their own pharmaceutical assistance programs for residents who meet income and eligibility requirements.

The article concludes by emphasizing that managing prescription costs without insurance takes effort but that real options exist at every step of the process. From the doctor’s office to the pharmacy counter, Prescription Savings Expert Carl Stecker’s perspective reinforces the article’s message that asking the right questions is one of the most reliable ways to keep medication costs manageable for uninsured patients.

How to Lower Prescription Costs When You Do Not Have Insurance features insights from Carl Stecker, Prescription Savings Expert of Greenville, South Carolina, in HelloNation.

About HelloNation

HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused digital publications and innovative “edvertising” approach, HelloNation delivers expert-driven, good-news content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

www.hellonation.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/in-hellonation-prescription-savings-expert-carl-stecker-outlines-how-to-lower-prescription-costs-without-insurance-302840150.html

SOURCE HelloNation

Continue Reading

Trending